Trials
Search / Trial NCT05639023

Orthopaedic Manipulation in Treatment of Adolescent Idiopathic Scoliosis

Launched by CHINESE UNIVERSITY OF HONG KONG · Nov 25, 2022

Trial Information

Current as of February 05, 2025

Unknown status

Keywords

ClinConnect Summary

After being informed about the study and potential risk, all patients giving written informed consent will undergo a 0-week screening period to determine eligibility for study entry. At week 0, patients who meet the eligibility requirements will be randomized in a single-blind manner(participant) in a 1:1 ratio to Manipulation Techniques Group or Control Group.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Adolescents aged between 10 and 18 who can speak and read Chinese
  • 2. Fulfil the diagnostic criteria of scoliosis, i.e. Cobb's angle ≥ 10 degree
  • 3. Risser grade ranging from 0 to 4
  • 4. Informed consent agreement signed by both subject and their parents/guardians
  • 5. Able to participate in follow-up assessments
  • Exclusion Criteria:
  • 1. History of spine surgery;
  • 2. Cobb's angle \>30 degrees
  • 3. Known to have severe respiratory or cardiovascular comorbidities; vertebral tumours and spinal canal abnormalities; Leukaemia, thrombocytopenia and other bleeding disorders
  • 4. Known to have cognitive impairment.
  • 5. Documented pregnancy
  • 6. Wearing brace within 1 month.
  • 7. Involved in other interventional clinical studies at the same time.
  • 8. Uncooperative during treatments
  • 9. Being assessed by investigators as unsuitable to participate.

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials